Conference or Workshop Item
Suppressed or unsuppressed HIV in adults on antiretroviral therapy in Zambia: who is at risk? (2012)
Chishinga, N; Godfrey-Faussett, P; Fielding, K; Grant, A; Schaap, A; Ayles, H
grid_on
Cost-effectiveness of isoniazid preventive therapy of averting tuberculosis among HIV-infected employees in South Africa: evaluation of a randomised intervention Abstract [TuOrD1210]. (2004)
Kumaranayake, L; Fielding, K; Grant, A; Roux, S; Charalambous, S; Day, J; Churchyard, G
Factors associated with pregnancy during the HVTN 503/Phambili trial, a phase IIB HIV trial of the Merck Ad-5 multi-clade HIV vaccine. (2009)
Latka, M; Grey, G; Fielding, K; Bekker, L; Mlisana, K; Nchabeleng, M; Debruin, G; Allen, M; Kublin, J; Churchyard, G
html
How Well Do Potential Trial Participants Understand Vaccine Trial Concepts?: Findings from South Africans Recruited for HVTN 204 and 503 Vaccine Trials. (2008)
Latka, MH; Nielson, T; Persotam, S; Moola, F; Wessie, G; Fielding, KL; Churchyard, GJ
Considering the design effect for the stepped wedge trial: what can it tell us? (2015)
Thompson, J; Fielding, K; Hargreaves, J; Copas, A
A reanalysis of the Brazil XpertMTB/RIF stepped wedge trial using a novel cluster summary analysis method. (2016)
Thompson, JA; Davey, C; Fielding, K; Hargreaves, J; Hayes, RJ
The optimal design of the stepped wedge trial and a comparison to other trial designs. (2017)
Thompson, JA; Fielding, K; Hargreaves, J; Copas, A
Implications of Misspecifed Mixed Effect Models in Stepped Wedge Trial Analysis: How Wrong Can It Be? (2016)
Thompson, JA; Fielding, KL; Davey, C; Aiken, AM; Hargreaves, JR; Hayes, RJ
The effect of antiretroviral therapy on chest radiograph appearance in HIV-associated pulmonary tuberculosis. (2013)
van Halsema, C; Chihota, V; Gorsuch, T; Lewis, J; George, E; Fielding, K; Churchyard, G; Grant, A